Annovis Bio GAAP EPS of -$0.40 beats by $0.05
· seekingalpha.com
Annovis Bio press release (ANVS): Q2 GAAP EPS of -$0.40 beats by $0.05. Annovis’ cash and cash equivalents totaled $18.7 million as of June 30, 2026
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...